{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T10:29:36Z","timestamp":1779013776901,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Vanderbilt Clinical and Translational Science Awards","award":["UL1 TR000445"],"award-info":[{"award-number":["UL1 TR000445"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23HL119602"],"award-info":[{"award-number":["K23HL119602"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32DK007061"],"award-info":[{"award-number":["T32DK007061"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ghir.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T09:07:05Z","timestamp":1449911225000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-5830","authenticated-orcid":false,"given":"Jessica R.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Utz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Devin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2015.12.005_bb0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ghir.2015.03.001","article-title":"The robustness of diagnostic tests for GH deficiency in adults","volume":"25","author":"Andersen","year":"2015","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2015.12.005_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/eje.0.1430099","article-title":"Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans","volume":"143","author":"Arvat","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/jcem-70-5-1371","article-title":"Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man","volume":"70","author":"Barbetti","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1258\/acb.2008.008074","article-title":"Standardization of the IMMULITE systems growth hormone assay with the recombinant IS 98\/574","volume":"45","author":"Barth","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ghir.2015.12.005_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-09-0824","article-title":"Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery","volume":"162","author":"Berg","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0030","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1210\/jc.2007-0153","article-title":"Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency","volume":"92","author":"Brabant","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2007.08.015","article-title":"Impact of 5years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults","volume":"57","author":"Cenci","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2015.12.005_bb0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/BF03345251","article-title":"Glucagon stimulation test for the diagnosis of GH deficiency in adults","volume":"26","author":"Conceicao","year":"2003","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2015.12.005_bb0045","first-page":"4350","article-title":"Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism","volume":"83","author":"Cordido","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11102-007-0031-0","article-title":"Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood","volume":"10","author":"Corneli","year":"2007","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2015.12.005_bb0060","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1210\/jc.2014-2830","article-title":"Overweight\/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency","volume":"99","author":"Dichtel","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0065","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s11102-015-0666-1","article-title":"Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?","author":"Diri","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2015.12.005_bb0070","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1210\/jc.2009-0614","article-title":"Bioactive insulin-like growth factor-I in obesity","volume":"94","author":"Frystyk","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0075","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ghir.2008.06.002","article-title":"Relationship between GH response and glycemic fluctuations in the glucagon stimulation test","volume":"19","author":"Giuffrida","year":"2009","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2015.12.005_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2265.2002.01472.x","article-title":"Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults","volume":"56","author":"Gomez","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ghir.2015.12.005_bb0095","first-page":"2013","article-title":"Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19\u201382years, in relation to those in healthy subjects","volume":"84","author":"Hilding","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0100","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI105358","article-title":"The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa","volume":"45","author":"Landon","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2015.12.005_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.2001.01169.x","article-title":"An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease","volume":"54","author":"Leong","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2015.12.005_bb0125","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1210\/jc.2005-1207","article-title":"Estrogen replacement in women of fertile years with hypopituitarism","volume":"90","author":"Mah","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0130","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0135","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1365-2265.1998.00610.x","article-title":"Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST)","volume":"49","author":"Orme","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0140","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2013-1099","article-title":"Approach to testing growth hormone (GH) secretion in obese subjects","volume":"98","author":"Popovic","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)","volume":"89","author":"Rosilio","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cmet.2013.09.002","article-title":"Profiling of glucose-sensing neurons reveals that GHRH neurons are activated by hypoglycemia","volume":"18","author":"Stanley","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/bmj.1.5851.489","article-title":"Glucagon and growth hormone","volume":"1","author":"Stimmler","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ghir.2015.12.005_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2015.12.005_bb0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4158\/EP11146.OR","article-title":"Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation tests","volume":"18","author":"Toogood","year":"2012","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ghir.2015.12.005_bb0175","first-page":"460","article-title":"Beyond the somatopause: growth hormone deficiency in adults over the age of 60years","volume":"81","author":"Toogood","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-72-1-51","article-title":"Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man","volume":"72","author":"Veldhuis","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.12.005_bb0185","first-page":"608056","article-title":"Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives","volume":"2011","author":"Yuen","year":"2011","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.ghir.2015.12.005_bb0190","first-page":"220","article-title":"Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults","author":"Yuen","year":"2012","journal-title":"Pituitary"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:49:04Z","timestamp":1761086944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637415300423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"alternative-id":["S1096637415300423"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2015.12.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726089624.793538651","asserted-by":"object"}]},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}